Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.

Biotechnology

Medical Devices

Therapeutics

Kate Therapeutics

Kate Therapeutics' headquarters in San Diego, CA, United States

Kevin Forrest

Ana Maria Manso-Martin

Jana Jenquin

Beth Seidenberg

Rob Fiorentino

Nathan Jones

Sharif Tabebordbar

Aislinn Puga

The Research and Development team at Kate Therapeutics focuses on innovating and advancing AAV-based gene therapies for muscle and heart diseases. Comprising a diverse group of scientists and researchers, the team conducts experiments to optimize gene delivery mechanisms, enhance safety profiles, and improve therapeutic efficacy. Their work involves developing new technology platforms, characterizing AAV capsids, and designing preclinical studies to facilitate the transition of promising therapies from the lab to clinical application.

Research and Development

The Leadership Team at Kate Therapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative AAV-based gene therapies. This diverse team of experts collaborates to advance research and development, oversee clinical and operational initiatives, and drive business growth, ensuring that KateTx meets its goal of addressing genetically defined muscular and cardiac diseases through cutting-edge therapeutic solutions.

Leadership Team

The Clinical Operations team at Kate Therapeutics plays a pivotal role in the design, implementation, and management of clinical trials for AAV-based gene therapies. They ensure compliance with regulatory standards, oversee trial logistics, and collaborate with cross-functional teams to streamline the development process, ultimately aiming to advance innovative treatments for genetically defined muscle and heart diseases.

Kate Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Clinical Operations

Offices

Kate Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Clinical Operations

Offices

Related companies